Device type · NGV
System, Appendage Closure, Left Atrial
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NGV
Cardiovascular
Device class
Class III
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
2,621
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Appendage Closure, Left Atrial
- Product code
- NGV
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for NGV
Latest FDA decisions
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure Technology, WATCHMAN FLX Left Atrial Appendage Closure Device with DeliPMA supplement
P130013-S074 · Decided Jul 16, 2025 · 180 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
P200049 · Decided Aug 14, 2021 · 226 days after receipt
Device type: System, appendage closure, left atrial (NGV) · Cardiology
- WATCHMAN FLX Left Atrial Appendage Closure Device with Delivery System and WATCHMAN Left Atrial Appendage Closure DevicePMA supplement
P130013-S035 · Decided Jul 21, 2020 · 201 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
P130013 · Decided Mar 13, 2015 · 668 days after receipt
Device type: System, appendage closure, left atrial (NGV) · Cardiology
Reports received
2,621
Received Nov 1, 2025 to Nov 19, 2026. Includes 6 of another or unstated type.
Malfunction reports
143
5.5% of reports
Injury reports
2,156
82% of reports
Death reports
316
12% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 21 | 131 | 16 | 0 |
| Jan 24 | 18 | 537 | 152 | 0 |
| Feb 24 | 14 | 150 | 7 | 0 |
| Mar 24 | 20 | 122 | 20 | 0 |
| Apr 24 | 20 | 182 | 21 | 0 |
| May 24 | 16 | 162 | 30 | 0 |
| Jun 24 | 18 | 204 | 28 | 0 |
| Jul 24 | 19 | 179 | 21 | 0 |
| Aug 24 | 15 | 94 | 9 | 0 |
| Sep 24 | 22 | 130 | 11 | 0 |
| Oct 24 | 9 | 143 | 25 | 0 |
| Nov 24 | 15 | 98 | 18 | 0 |
| Dec 24 | 17 | 135 | 17 | 0 |
| Jan 25 | 23 | 331 | 70 | 0 |
| Feb 25 | 10 | 114 | 9 | 0 |
| Mar 25 | 11 | 119 | 16 | 0 |
| Apr 25 | 9 | 134 | 16 | 0 |
| May 25 | 12 | 177 | 15 | 0 |
| Jun 25 | 17 | 168 | 16 | 0 |
| Jul 25 | 11 | 451 | 116 | 0 |
| Aug 25 | 12 | 182 | 19 | 0 |
| Sep 25 | 13 | 169 | 25 | 0 |
| Oct 25 | 8 | 181 | 22 | 0 |
| Nov 25 | 17 | 129 | 9 | 0 |
| Dec 25 | 13 | 181 | 34 | 0 |
| Jan 26 | 16 | 365 | 91 | 0 |
| Feb 26 | 5 | 174 | 27 | 0 |
| Mar 26 | 7 | 182 | 27 | 0 |
| Apr 26 | 15 | 171 | 30 | 0 |
| May 26 | 10 | 140 | 17 | 0 |
| Jun 26 | 10 | 162 | 19 | 0 |
| Jul 26 | 11 | 150 | 15 | 0 |
| Aug 26 | 13 | 120 | 15 | 3 |
| Sep 26 | 10 | 194 | 12 | 2 |
| Oct 26 | 16 | 188 | 20 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Boston Scientific2,034
- Abbott581
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem1,644
- Failure to Seal342
- Migration229
- Migration or Expulsion of Device122
- Patient Device Interaction Problem102
- Device Dislodged or Dislocated101
- Patient-Device Incompatibility89
- Premature Separation44
- Material Deformation40
- Nonstandard Device23
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions794
- Pericardial Effusion667
- Thrombosis/Thrombus525
- Cardiac Tamponade270
- Stroke/CVA266
- Low Blood Pressure/ Hypotension230
- Cardiac Perforation130
- Hemorrhage/Blood Loss/Bleeding98
- Cardiac Arrest97
- Transient Ischemic Attack87
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0191-2027 · Started Sep 10, 2026 · Posted by FDA Oct 16, 2026
Reason given: Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).
Cause as FDA categorized it: Labeling design
Z-2878-2018 · Started May 7, 2018
Reason given: When attempting to recapture the 32-mm device, the tip of the delivery sheath may fold or buckle, resulting in increased retraction force and difficulty or failure to recapture the device.
Cause as FDA categorized it: Component design/selection
Z-2765-2015 · Started Aug 25, 2015
Reason given: Cross-threading of the hemostasis valve may occur if it is tightened with the dilator in place, possibly preventing subsequent sealing of the valve when desired. This Field Correction reinforces the Directions for Use (DFU) and gives further guidance on correct use of the hemostasis valve to avoid cross-threading and...
Cause as FDA categorized it: Use error
Z-2766-2015 · Started Aug 25, 2015
Reason given: Cross-threading of the hemostasis valve may occur if it is tightened with the dilator in place, possibly preventing subsequent sealing of the valve when desired. This Field Correction reinforces the Directions for Use (DFU) and gives further guidance on correct use of the hemostasis valve to avoid cross-threading and...
Cause as FDA categorized it: Use error
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.